feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / India's Glaucoma Fight: First 3D Angiography Performed

India's Glaucoma Fight: First 3D Angiography Performed

2 Jan

•

Summary

  • India successfully performed its first 3D Flex Aqueous Angiography with iStent.
  • The procedure uses advanced 3D imaging to improve fluid drainage in the eye.
  • This new technology aims to combat irreversible blindness caused by glaucoma.
India's Glaucoma Fight: First 3D Angiography Performed

The Army Hospital (Research & Referral), Delhi Cantt, has achieved a major milestone in eye care by performing India's first 3D Flex Aqueous Angiography with iStent. This innovative glaucoma treatment utilizes high-clarity 3D imaging to map fluid drainage pathways inside the eye, enabling surgeons to precisely place an iStent. This tiny implant enhances drainage and reduces pressure, crucial for preventing blindness caused by glaucoma.

The procedure was made possible by the recent introduction of a movable Spectralis system and a 3D operating microscope, offering real-time, magnified views of the eye's drainage channels. Glaucoma is a leading cause of irreversible blindness in India, often detected late due to its asymptomatic nature in early stages. This new technology allows for earlier and more accurate targeting of blocked channels, promising better long-term patient outcomes.

Following this success, the Armed Forces Medical Services plans to implement the same system at Command Hospital in Lucknow. This expansion will significantly enhance advanced glaucoma care for nearly 3.5 lakh patients across six states and Nepal, addressing a critical need in combating vision loss.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The Army Hospital in Delhi performed India's first 3D Flex Aqueous Angiography with iStent for glaucoma treatment.
The iStent is a tiny implant that improves fluid drainage inside the eye, reducing pressure and preventing glaucoma-related blindness.
The new system will be introduced at Command Hospital, Lucknow, to enhance advanced glaucoma care.

Read more news on

Healthside-arrow
trending

Salesforce lays off 1000

trending

India US trade tariffs slashed

trending

Margot Robbie's Wuthering Heights panned

trending

CBSE board exams: key details

trending

Jana Nayagan movie court case

trending

Dhakshineswar Suresh Davis Cup hero

trending

Deepika Padukone wears Gaurav Gupta

trending

NZ vs UAE match prediction

trending

iPhone 17 Croma Valentine's sale

You may also like

MBBS Student Found Dead With Acid Bottle

11 hours ago • 5 reads

article image

Lucknow Lab Expands Services Under Hub-and-Spoke Model

7 Feb • 17 reads

article image

Tiny Survivor: Preemie Baby Weighing Under 1kg Saved

2 Feb • 42 reads

article image

Lucknow Hospital Aims for Medical College Status

4 Feb • 43 reads

article image

Organ Donor's Liver Travels Miles to Save Life

24 Jan • 104 reads

article image